KHI Board of Directors and Federal Liaisons
Chair
- Uptal D. Patel, MD (2025)
FDA Point of Contact
- Kristen Miller, PharmD (2024)
Members
- Shuchi Anand, MD, MS (2027)
- Steven K. Burke, MD (2027)
- Jorge Cerda, MD, MS, FASN (2025)
- Bruce F. Culleton, MD (2025)
- Manisha Dadhania, MBA (2025)
- Ogo I. Egbuna, MD, MSc, FASN (2027)
- Vanessa A. Evans, MA (2025)
- Jennifer E. Flythe, MD, MPH, FASN (2024)
- Kevin John Fowler (2025)
- Amanda Grandinetti, MPH (2025)
- Nicolas Jose Guzman, MD (2024)
- Meg Jardine, MBBS, PhD (2025)
- Annamaria T. Kausz, MD, MS (2024)
- Lauren L. Lee, MA (2027)
- Vandana Dua Niyyar, MD, FASN (2026)
- Ikenna Okezie, MD, MBA (2025)
- Robert M. Perkins, MD, MPH (2027)
- Glenda V. Roberts (2025)
- Bruce M. Robinson, MD, MS, FASN (2025)
- Alain Romero, PharmD, PhD (2025)
- Brigitte Schiller, MD, FASN (2025)
- Amit Sharma, MD, FASN (2025)
- Robert A. Star, MD (2024)
- Howard Trachtman, MD, FASN (2026)
- Amy Young (2025)
FDA Liaisons
- Aliza M. Thompson, MD, MS (2025)
- Celia Witten, MD, PhD (2025)
Council Liaison
- Linda F. Fried, MD, FASN, MPH (2025)
Disclosures as of September 2021 can be found here.